![]() Sellas Life Sciences SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. | ![]() Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | ![]() Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. | |
Founding Date | Founding Date 2006 | Founding Date 2015 | Founding Date 1996 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations New York, US HQ New York, US | Locations Écully, FR HQ Cambridge, US | Locations Eastwood, AU HQ |
Employees | Employees 538% decrease | Employees 373% decrease | Employees 7 |
Financial | |||
Net income | Net income ($26.9m) (FY, 2025) | Net income N/A | Net income ($21.8m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 93.1m | Total funding raised $ 10.4m |

Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company
Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders.
View company